Biocartis Group NV (EBR:BCART)
Belgium · Delayed Price · Currency is EUR 0.2900
0.00 (0.00%)
Last updated: Dec 18, 2025, 9:00 AM CET
Biocartis Group NV Market Cap
Biocartis Group NV has a market cap or net worth of €27.24 million as of January 20, 2026.
Market Cap
27.24M
Enterprise Value
26.59M
Revenue
47.69M
Ranking
n/a
PE Ratio
1.48
Stock Price
€0.29
Market Cap Chart
Since April 27, 2015, Biocartis Group NV's market cap has decreased from 525.83M to 27.24M, a decrease of -94.82%. That is a compound annual growth rate of -24.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 27.24M | - |
| Dec 31, 2025 | 27.24M | - |
| Dec 31, 2024 | 27.24M | - |
| Dec 29, 2023 | 27.24M | -43.87% |
| Dec 30, 2022 | 48.52M | -76.68% |
| Dec 31, 2021 | 208.03M | -22.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 49.00B |
| argenx SE | 41.97B |
| Financière de Tubize | 10.04B |
| Fagron NV | 1.66B |
| Ion Beam Applications | 436.07M |
| Hyloris Pharmaceuticals | 212.80M |
| Onward Medical | 197.06M |
| Nyxoah | 176.41M |